The findings in the present study indicate protective effect of fish oil supplementation in this dyslipidemia model as demonstrated by the reduction of plasma concentration and hepatic content of triglycerides, besides improvement in hepatic steatosis, observed in histopathological analysis, decrease in hepatic concentration of MPO, and increase in erythrocyte SOD concentration. The gene discussed is MPO; the disease is metabolic syndrome.